Last 12 months
Inside the activity.
2 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 2 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 10, 2026 Filed Jun 12, 2026 16:23 UTC |
Joseph MollyDirector
|
GrantCommon Stock | 19,358 | $0.00 | $0.00 |
DisclosureSEC source: 0000905148-26-002936 · form4.xml · nonDerivative · entry 1 Joseph Molly · CIK 0001709261 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 46,385 F1 · shares: Represents restricted stock units ("RSUs"), each one of which represents the contingent right to receive one share of the Issuer's common stock. The RSUs will vest on the earlier of the one-year anniversary of the grant date and the next annual meeting of the Issuer's stockholders following the grant date, subject to the Reporting Person's continued service with the Issuer. Read SEC document |
| June 10, 2026 Filed Jun 12, 2026 16:21 UTC |
BRODNAX BRETTDirector
|
GrantCommon Stock | 19,358 | $0.00 | $0.00 |
DisclosureSEC source: 0000905148-26-002933 · form4.xml · nonDerivative · entry 1 BRODNAX BRETT · CIK 0001242772 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 81,385 F1 · shares: Represents restricted stock units ("RSUs"), each one of which represents the contingent right to receive one share of the Issuer's common stock. The RSUs will vest on the earlier of the one-year anniversary of the grant date and the next annual meeting of the Issuer's stockholders following the grant date, subject to the Reporting Person's continued service with the Issuer. Read SEC document |
| June 10, 2026 Filed Jun 12, 2026 16:22 UTC |
EISENBERG GLENN ADirector
|
GrantCommon Stock | 19,358 | $0.00 | $0.00 |
DisclosureSEC source: 0000905148-26-002935 · form4.xml · nonDerivative · entry 1 EISENBERG GLENN A · CIK 0001222831 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,358 F1 · shares: Represents restricted stock units ("RSUs"), each one of which represents the contingent right to receive one share of the Issuer's common stock. The RSUs will vest on the earlier of the one-year anniversary of the grant date and the next annual meeting of the Issuer's stockholders following the grant date, subject to the Reporting Person's continued service with the Issuer. Read SEC document |
| June 10, 2026 Filed Jun 12, 2026 20:23 UTC |
Karlin Bridget EDirector
|
GrantCommon Stock | 19,358 | $0.00 | $0.00 |
DisclosureSEC source: 0000905148-26-002937 · form4.xml · nonDerivative · entry 1 Karlin Bridget E · CIK 0001797157 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,358 F1 · shares: Represents restricted stock units ("RSUs"), each one of which represents the contingent right to receive one share of the Issuer's common stock. The RSUs will vest on the earlier of the one-year anniversary of the grant date and the next annual meeting of the Issuer's stockholders following the grant date, subject to the Reporting Person's continued service with the Issuer. Read SEC document |
| June 10, 2026 Filed Jun 12, 2026 16:22 UTC |
Cooper Henry LeeDirector
|
GrantCommon Stock | 19,358 | $0.00 | $0.00 |
DisclosureSEC source: 0000905148-26-002934 · form4.xml · nonDerivative · entry 1 Cooper Henry Lee · CIK 0001799418 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,358 F1 · shares: Represents restricted stock units ("RSUs"), each one of which represents the contingent right to receive one share of the Issuer's common stock. The RSUs will vest on the earlier of the one-year anniversary of the grant date and the next annual meeting of the Issuer's stockholders following the grant date, subject to the Reporting Person's continued service with the Issuer. Read SEC document |
| June 10, 2026 Filed Jun 12, 2026 20:24 UTC |
Mittl Robert Louis Jr.Director
|
GrantCommon Stock | 19,358 | $0.00 | $0.00 |
DisclosureSEC source: 0000905148-26-002939 · form4.xml · nonDerivative · entry 1 Mittl Robert Louis Jr. · CIK 0002101243 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,358 F1 · shares: Represents restricted stock units ("RSUs"), each one of which represents the contingent right to receive one share of the Issuer's common stock. The RSUs will vest on the earlier of the one-year anniversary of the grant date and the next annual meeting of the Issuer's stockholders following the grant date, subject to the Reporting Person's continued service with the Issuer. Read SEC document |
| June 10, 2026 Filed Jun 12, 2026 20:24 UTC |
Lungren MatthewDirector
|
GrantCommon Stock | 19,358 | $0.00 | $0.00 |
DisclosureSEC source: 0000905148-26-002938 · form4.xml · nonDerivative · entry 1 Lungren Matthew · CIK 0002100694 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,358 F1 · shares: Represents restricted stock units ("RSUs"), each one of which represents the contingent right to receive one share of the Issuer's common stock. The RSUs will vest on the earlier of the one-year anniversary of the grant date and the next annual meeting of the Issuer's stockholders following the grant date, subject to the Reporting Person's continued service with the Issuer. Read SEC document |
| May 19, 2026 Filed May 21, 2026 16:20 UTC |
BRODNAX BRETTDirector
|
PurchaseCommon Stock | 35,000 | $7.25 | $253,750.00 |
DisclosureSEC source: 0000905148-26-002611 · form4.xml · nonDerivative · entry 1 BRODNAX BRETT · CIK 0001242772 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 62,027 Read SEC document |
| May 14, 2026 Filed May 18, 2026 16:12 UTC |
Cooper Henry LeeDirector
|
PurchaseCommon Stock | 30,000 | $7.44 | $223,113.00 |
DisclosureSEC source: 0000905148-26-002503 · form4.xml · nonDerivative · entry 1 Cooper Henry Lee · CIK 0001799418 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Cooper Family Trust Disclosed balance after: 30,000 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $7.32 to $7.50, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth herein. F2 · ownership.nature: These shares are directly owned by Cooper Family Trust, a revocable trust of which the Reporting Person and his spouse serve as co-trustees. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of the reported shares for purposes of Section 16 or for any other purposes. Read SEC document |
| February 25, 2026 Filed Feb 27, 2026 22:40 UTC |
Walker James Edward Jr.Principal Accounting Officer
|
GrantCommon Stock | 12,414 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-083296 · ownership.xml · nonDerivative · entry 1 Walker James Edward Jr. · CIK 0002102971 · Principal Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,346 F1 · shares: Represents restricted stock units ("RSUs"), each one of which represents the contingent right to receive one share of the Issuer's common stock. The RSUs will vest annually in three substantially equal installments on each of the first three anniversaries of the grant date, subject to the Reporting Person's continued service with the Issuer. Read SEC document |
| December 12, 2025 Filed Dec 16, 2025 22:50 UTC |
Zulla CaitlinDirector · Chief Executive Officer
|
GrantCommon Stock | 64,864 | $0.00 | $0.00 |
DisclosureSEC source: 0000905148-25-004390 · form4.xml · nonDerivative · entry 2 Zulla Caitlin · CIK 0002031509 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 129,728 F2 · shares: Represents RSUs, each one of which represents the contingent right to receive one share of Common Stock. The RSUs will vest in three substantially equal installments upon the attainment of three prescribed stock price targets of $27.00, $36.00 and $45.00 per share, which targets are measured based on the volume weighted average closing price per share of Common Stock over any consecutive sixty (60) trading day period, with the measurement period commencing on the first business day immediately following the expiration of the 180-day lock-up period and continuing until the three-year anniversary of the grant date (the "First Vesting Date"), subject to the Reporting Person's continued service with the Issuer through the First Vesting Date. [continues in footnote 3] F3 · shares: [continued from footnote 2] If any of the stock price targets have not been achieved as of the First Vesting Date, then the remaining unvested RSUs shall remain outstanding and eligible to vest through the four-year anniversary of the grant date (the "Second Vesting Date"), with the measurement period extended to the Second Vesting Date. Read SEC document |
| December 12, 2025 Filed Dec 16, 2025 22:50 UTC |
Zulla CaitlinDirector · Chief Executive Officer
|
GrantCommon Stock | 64,864 | $0.00 | $0.00 |
DisclosureSEC source: 0000905148-25-004390 · form4.xml · nonDerivative · entry 1 Zulla Caitlin · CIK 0002031509 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 64,864 F1 · shares: Represents restricted stock units ("RSUs"), each one of which represents the contingent right to receive one share of the Issuer's common stock ("Common Stock"). The RSUs will vest annually in three substantially equal installments on each of the first three anniversaries of the grant date, subject to the Reporting Person's continued service with the Issuer. Read SEC document |
| December 12, 2025 Filed Dec 16, 2025 17:49 UTC |
Joseph MollyDirector
|
GrantCommon Stock | 27,027 | $0.00 | $0.00 |
DisclosureSEC source: 0000905148-25-004388 · form4.xml · nonDerivative · entry 1 Joseph Molly · CIK 0001709261 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,027 F1 · shares: Represents restricted stock units ("RSUs"), each one of which represents the contingent right to receive one share of the Issuer's common stock. 13,513 RSUs vested on the grant date, and the remaining RSUs will vest annually in three substantially equal installments on each of the first three anniversaries of the grant date, subject to the Reporting Person's continued service with the Issuer. Read SEC document |
| December 12, 2025 Filed Dec 16, 2025 17:49 UTC |
BRODNAX BRETTDirector
|
GrantCommon Stock | 27,027 | $0.00 | $0.00 |
DisclosureSEC source: 0000905148-25-004389 · form4.xml · nonDerivative · entry 1 BRODNAX BRETT · CIK 0001242772 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,027 F1 · shares: Represents restricted stock units ("RSUs"), each one of which represents the contingent right to receive one share of the Issuer's common stock. The RSUs will vest annually in three substantially equal installments on each of the first three anniversaries of the grant date, subject to the Reporting Person's continued service with the Issuer. Read SEC document |
| December 12, 2025 Filed Dec 16, 2025 22:49 UTC |
Szeker JulieChief Legal Officer & Corp Sec
|
Exercise / conversionIncentive Units of Holdings LLC · Derivative | 1,250,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000905148-25-004386 · form4.xml · derivative · entry 3 Szeker Julie · CIK 0002101138 · Chief Legal Officer & Corp Sec 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 66,182 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Represents incentive units ("Incentive Units") of Lumexa Imaging Equity Holdco, LLC ("Holdings LLC") held by the Reporting Person. At the closing of the Issuer's initial public offering ("IPO"), these Incentive Units were converted into shares of the Issuer's common stock ("Common Stock") based on the intrinsic value of the awards at the time of the Issuer's IPO, as determined by the board of managers of Holdings LLC, with any shares of Common Stock issued in replacement of unvested Incentive Units to be delivered as restricted stock awards, which remain subject to time-based and performance-based vesting conditions, as applicable. [continues in footnote 2] F2 · security: [continued from footnote 1] The time-based vesting schedule applicable to the replacement restricted stock awards replicates the original time-based vesting schedule applicable to the time-based Incentive Units prior to the closing of the Issuer's IPO, while the performance-based vesting conditions are tied to stock price triggers intended to replicate the performance-based vesting conditions applicable to the performance-based Incentive Units prior to the closing of the Issuer's IPO. F1 · derivative.exercise_price: Represents incentive units ("Incentive Units") of Lumexa Imaging Equity Holdco, LLC ("Holdings LLC") held by the Reporting Person. At the closing of the Issuer's initial public offering ("IPO"), these Incentive Units were converted into shares of the Issuer's common stock ("Common Stock") based on the intrinsic value of the awards at the time of the Issuer's IPO, as determined by the board of managers of Holdings LLC, with any shares of Common Stock issued in replacement of unvested Incentive Units to be delivered as restricted stock awards, which remain subject to time-based and performance-based vesting conditions, as applicable. [continues in footnote 2] F2 · derivative.exercise_price: [continued from footnote 1] The time-based vesting schedule applicable to the replacement restricted stock awards replicates the original time-based vesting schedule applicable to the time-based Incentive Units prior to the closing of the Issuer's IPO, while the performance-based vesting conditions are tied to stock price triggers intended to replicate the performance-based vesting conditions applicable to the performance-based Incentive Units prior to the closing of the Issuer's IPO. F1 · derivative.exercise_date: Represents incentive units ("Incentive Units") of Lumexa Imaging Equity Holdco, LLC ("Holdings LLC") held by the Reporting Person. At the closing of the Issuer's initial public offering ("IPO"), these Incentive Units were converted into shares of the Issuer's common stock ("Common Stock") based on the intrinsic value of the awards at the time of the Issuer's IPO, as determined by the board of managers of Holdings LLC, with any shares of Common Stock issued in replacement of unvested Incentive Units to be delivered as restricted stock awards, which remain subject to time-based and performance-based vesting conditions, as applicable. [continues in footnote 2] F2 · derivative.exercise_date: [continued from footnote 1] The time-based vesting schedule applicable to the replacement restricted stock awards replicates the original time-based vesting schedule applicable to the time-based Incentive Units prior to the closing of the Issuer's IPO, while the performance-based vesting conditions are tied to stock price triggers intended to replicate the performance-based vesting conditions applicable to the performance-based Incentive Units prior to the closing of the Issuer's IPO. F1 · derivative.expiration_date: Represents incentive units ("Incentive Units") of Lumexa Imaging Equity Holdco, LLC ("Holdings LLC") held by the Reporting Person. At the closing of the Issuer's initial public offering ("IPO"), these Incentive Units were converted into shares of the Issuer's common stock ("Common Stock") based on the intrinsic value of the awards at the time of the Issuer's IPO, as determined by the board of managers of Holdings LLC, with any shares of Common Stock issued in replacement of unvested Incentive Units to be delivered as restricted stock awards, which remain subject to time-based and performance-based vesting conditions, as applicable. [continues in footnote 2] F2 · derivative.expiration_date: [continued from footnote 1] The time-based vesting schedule applicable to the replacement restricted stock awards replicates the original time-based vesting schedule applicable to the time-based Incentive Units prior to the closing of the Issuer's IPO, while the performance-based vesting conditions are tied to stock price triggers intended to replicate the performance-based vesting conditions applicable to the performance-based Incentive Units prior to the closing of the Issuer's IPO. F3 · derivative.underlying_shares: Includes 11,876 shares of Common Stock that will vest upon the attainment of a prescribed stock price target of $24.97 per share, which target is measured based on the volume weighted average closing price per share of Common Stock over any consecutive sixty (60) trading day period, with the measurement period commencing on the first business day immediately following the expiration of the 180-day lock-up period, subject to the Reporting Person's continued service with the Issuer. Read SEC document |
| December 12, 2025 Filed Dec 16, 2025 22:49 UTC |
Szeker JulieChief Legal Officer & Corp Sec
|
GrantCommon Stock | 81,081 | $0.00 | $0.00 |
DisclosureSEC source: 0000905148-25-004386 · form4.xml · nonDerivative · entry 2 Szeker Julie · CIK 0002101138 · Chief Legal Officer & Corp Sec 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 147,263 F4 · shares: Represents restricted stock units ("RSUs"), each one of which represents the contingent right to receive one share of Common Stock. The RSUs will vest in full on December 12, 2026, subject to the Reporting Person's continued service with the Issuer. Read SEC document |
| December 12, 2025 Filed Dec 16, 2025 22:49 UTC |
Szeker JulieChief Legal Officer & Corp Sec
|
Exercise / conversionCommon Stock | 66,182 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000905148-25-004386 · form4.xml · nonDerivative · entry 1 Szeker Julie · CIK 0002101138 · Chief Legal Officer & Corp Sec 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 66,182 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Represents incentive units ("Incentive Units") of Lumexa Imaging Equity Holdco, LLC ("Holdings LLC") held by the Reporting Person. At the closing of the Issuer's initial public offering ("IPO"), these Incentive Units were converted into shares of the Issuer's common stock ("Common Stock") based on the intrinsic value of the awards at the time of the Issuer's IPO, as determined by the board of managers of Holdings LLC, with any shares of Common Stock issued in replacement of unvested Incentive Units to be delivered as restricted stock awards, which remain subject to time-based and performance-based vesting conditions, as applicable. [continues in footnote 2] F2 · price: [continued from footnote 1] The time-based vesting schedule applicable to the replacement restricted stock awards replicates the original time-based vesting schedule applicable to the time-based Incentive Units prior to the closing of the Issuer's IPO, while the performance-based vesting conditions are tied to stock price triggers intended to replicate the performance-based vesting conditions applicable to the performance-based Incentive Units prior to the closing of the Issuer's IPO. F3 · balance_after: Includes 11,876 shares of Common Stock that will vest upon the attainment of a prescribed stock price target of $24.97 per share, which target is measured based on the volume weighted average closing price per share of Common Stock over any consecutive sixty (60) trading day period, with the measurement period commencing on the first business day immediately following the expiration of the 180-day lock-up period, subject to the Reporting Person's continued service with the Issuer. Read SEC document |
| December 12, 2025 Filed Dec 16, 2025 22:49 UTC |
Stewart RussellChief Medical Officer
|
GrantCommon Stock | 4,232 | $0.00 | $0.00 |
DisclosureSEC source: 0000905148-25-004387 · form4.xml · nonDerivative · entry 2 Stewart Russell · CIK 0002101137 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,464 F2 · shares: Represents RSUs, each one of which represents the contingent right to receive one share of Common Stock. The RSUs will vest in three substantially equal installments upon the attainment of three prescribed stock price targets of $27.00, $36.00 and $45.00 per share, which targets are measured based on the volume weighted average closing price per share of Common Stock over any consecutive sixty (60) trading day period, with the measurement period commencing on the first business day immediately following the expiration of the 180-day lock-up period and continuing until the three-year anniversary of the grant date (the "First Vesting Date"), subject to the Reporting Person's continued service with the Issuer through the First Vesting Date. [continues in footnote 3] F3 · shares: [continued from footnote 2] If any of the stock price targets have not been achieved as of the First Vesting Date, then the remaining unvested RSUs shall remain outstanding and eligible to vest through the four-year anniversary of the grant date (the "Second Vesting Date"), with the measurement period extended to the Second Vesting Date. Read SEC document |
| December 12, 2025 Filed Dec 16, 2025 22:49 UTC |
Stewart RussellChief Medical Officer
|
GrantCommon Stock | 4,232 | $0.00 | $0.00 |
DisclosureSEC source: 0000905148-25-004387 · form4.xml · nonDerivative · entry 1 Stewart Russell · CIK 0002101137 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,232 F1 · shares: Represents restricted stock units ("RSUs"), each one of which represents the contingent right to receive one share of the Issuer's common stock ("Common Stock"). The RSUs will vest annually in three substantially equal installments on each of the first three anniversaries of the grant date, subject to the Reporting Person's continued service with the Issuer. Read SEC document |
| December 12, 2025 Filed Dec 30, 2025 19:01 UTC |
Walker James Edward Jr.Principal Accounting Officer
|
GrantCommon Stock | 4,932 | $0.00 | $0.00 |
DisclosureSEC source: 0000905148-25-004502 · form4.xml · nonDerivative · entry 1 Walker James Edward Jr. · CIK 0002102971 · Principal Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,932 F1 · shares: Represents restricted stock units ("RSUs"), each one of which represents the contingent right to receive one share of the Issuer's common stock. The RSUs will vest annually in three substantially equal installments on each of the first three anniversaries of the grant date, subject to the Reporting Person's continued service with the Issuer. Read SEC document |
| December 12, 2025 Filed Jan 15, 2026 17:51 UTC |
Martin James AnthonyChief Financial Officer
|
GrantCommon Stock | 27,027 | $0.00 | $0.00 |
DisclosureSEC source: 0000905148-26-000196 · form4.xml · nonDerivative · entry 2 Martin James Anthony · CIK 0002105348 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 54,054 F2 · shares: Represents RSUs, each one of which represents the contingent right to receive one share of Common Stock. The RSUs will vest in three substantially equal installments upon the attainment of three prescribed stock price targets of $27.00, $36.00 and $45.00 per share, which targets are measured based on the volume weighted average closing price per share of Common Stock over any consecutive sixty (60) trading day period, with the measurement period commencing on the first business day immediately following the expiration of the 180-day lock-up period and continuing until the three-year anniversary of the grant date (the "First Vesting Date"), subject to the Reporting Person's continued service with the Issuer through the First Vesting Date. [continues in footnote 3] F3 · shares: [continued from footnote 2] If any of the stock price targets have not been achieved as of the First Vesting Date, then the remaining unvested RSUs shall remain outstanding and eligible to vest through the four-year anniversary of the grant date (the "Second Vesting Date"), with the measurement period extended to the Second Vesting Date. Read SEC document |
| December 12, 2025 Filed Jan 15, 2026 17:51 UTC |
Martin James AnthonyChief Financial Officer
|
GrantCommon Stock | 27,027 | $0.00 | $0.00 |
DisclosureSEC source: 0000905148-26-000196 · form4.xml · nonDerivative · entry 1 Martin James Anthony · CIK 0002105348 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,027 F1 · shares: Represents restricted stock units ("RSUs"), each one of which represents the contingent right to receive one share of the Issuer's common stock ("Common Stock"). The RSUs will vest annually in three substantially equal installments on each of the first three anniversaries of the grant date, subject to the Reporting Person's continued service with the Issuer. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.